Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2025 Earnings Call Transcript
Dominik Heger: Thank you, Sandra. I would like to welcome everyone to our earnings call for the first quarter 2025.
Posts Tagged ‘NYSE:FMS’
8 Most Undervalued Healthcare Stocks to Buy According to Analysts
Healthcare prices and expenditures have been rising in the United States.
12 Best German Stocks to Buy According to Hedge Funds
Germany's economy is facing continued weakness.
Fresenius Medical Care AG (NYSE:FMS): On a Healing Path
We came across a bullish thesis on Fresenius Medical Care AG (NYSE:FMS) on ValueInvestorsClub by mimval. In this article, we will summarize the bulls’ thesis on FMS.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2024 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2024 Earnings Call Transcript February 25, 2025Fresenius Medical Care AG & Co. KGaA beats earnings expectations.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q3 2024 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q3 2024 Earnings Call Transcript November 5, 2024Fresenius Medical Care AG & Co. KGaA beats earnings expectations.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q2 2024 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q2 2024 Earnings Call Transcript July 30, 2024Fresenius Medical Care AG & Co. KGaA reports earnings inline with expectations.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA beats earnings expectations. Reported EPS is $0.36, expectations were $0.26. Fresenius Medical Care AG & Co.
What Makes Fresenius Medical Care AG (FMS) a Potential Investment?
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2023 Earnings Call Transcript
Fresenius Medical Care AG & Co. KGaA beats earnings expectations. Reported EPS is $0.44, expectations were $0.36. Fresenius Medical Care AG & Co.
What Makes Fresenius Medical Care AG (FMS) an Investment Bet?
Broyhill Asset Management, a boutique investment firm, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. I'm Andrea, your Chorus Call operator.
12 Best German Stocks To Buy Now
In this piece, we will take a look at the 12 best German stocks to buy now.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Emma, your Chorus Call operator.
11 Best Medical Stocks Under $10
In this piece, we will take a look at the eleven best medical stocks under $10.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. I'm Timo your Chorus Call operator.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. I am Nicolas, your Chorus Call operator.
10 Best German Dividend Stocks to Buy
In this article, we will take a look at the 10 best German dividend stocks to buy.
5 Best German Stocks to Buy Now
MorphoSys AG (NASDAQ:MOR) is a commercial-stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic antibodies for patients...
Should You Now Sell Fresenius Medical Care AG & Co. KGaA (FMS)?
Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
5 Best European Dividend Stocks to Buy Now
In this article, we discuss 5 best European dividend stocks to buy now.
10 Best European Dividend Stocks to Buy Now
In this article, we will discuss the 10 best European dividend stocks to buy now.
25 Biggest Pharmaceutical Companies in the World A Year Ago
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
5 Biggest Hospital Companies in the World
In this article, we take a look at the 5 biggest hospital companies in the world.
Here’s Why Fresenius Medical Care (FMS) Landed in Artisan Partners’ Detractor List
Artisan Partners, a high value-added investment management firm, published its “Artisan Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded...
Is it Still Worthy to Keep Your Fresenius Medical Care (FMS) Shares?
Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ fourth quarter 2021 investor letter – a copy of which can...
Is Fresenius Medical Care (FMS) A Smart Investment Choice?
Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ third quarter 2021 investor letter – a copy of which can...
Here’s Why Fresenius Medical (FMS) Became One of Artisan International’s Worst Stock Performers
Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ first quarter 2021 investor letter – a copy of which can...
Fresenius Medical (FMS) is a “Dependable Top-Line Grower”, Says Fiduciary Management
Fiduciary Management Inc., an investment management firm, published its “International Equity” first quarter 2021 investor letter – a copy of which can be downloaded here...
Is FMS A Good Stock To Buy Now?
In this article we will take a look at whether hedge funds think Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a good investment right now.
Hedge Funds Are Souring On Fresenius Medical Care AG & Co. KGaA (FMS)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been This Bullish On Fresenius Medical Care AG & Co. (FMS)
We hate to say this but, we told you so.
Hedge Funds Are Dumping Fresenius Medical Care AG & Co. KGaA (FMS)
Is Fresenius Medical Care AG & Co.
Hedge Funds Have Never Been This Bullish On Fresenius Medical Care AG & Co. KGaA (FMS)
Is Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Hedge Funds Have Never Been This Bullish On Fresenius Medical Care AG (FMS)?
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Fresenius Medical Care AG & Co. (FMS): Are Hedge Funds Right About This Stock?
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Fresenius Medical Care AG & Co. (ADR) (FMS): Are Hedge Funds Right About This Stock?
We know that hedge funds generate strong risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
This Under-The-Radar Stock Could Save A Buffett Favorite Millions
One of his recent favorites is DaVita HealthCare Partners Inc (NYSE:DVA), which operates a network of dialysis treatment centers in the United States catering to patients that...
Medical Device Industry Faces a Rising Demand Curve
In the midst of an aging population, the United States remains the market leader for medical devices, accounting for about one-third of the worldwide market.
Rockwell Medical Inc (RMTI), DaVita HealthCare Partners Inc (DVA): Why Are Investors Thrilled About This Company’s Iron Treatment?
Shares of Rockwell Medical Inc (NASDAQ:RMTI) soared recently, after the dialysis treatment company announced positive results regarding a study of its iron replacement drug...
Medtronic, Inc. (MDT), DaVita HealthCare Partners Inc (DVA): Can This Medical Device Maker’s Pacemaker Keep On Ticking?
In the medical technology industry, there is a clear divide between software and hardware.
Mednax Inc. (MD): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
To the average investor, there are many indicators market participants can use to analyze their holdings. A duo of the best are hedge fund and insider trading activity.
Do Hedge Funds and Insiders Love HEALTHSOUTH Corp. (HLS)?
To the average investor, there are a multitude of indicators market participants can use to analyze their holdings.
DaVita HealthCare Partners Inc (DVA), Fresenius Medical Care AG & Co. (ADR) (FMS): How to Profit From Obesity
Obesity rates are soaring in the United States. According to the American Heart Association, 155 million adults and 24 million children are overweight or obese.
Hospira, Inc. (HSP), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Shortage of Execution Drugs on the Firing Line
Maybe Texas just needs to fire up Ol' Sparky again.
Amgen, Inc. (AMGN), DaVita HealthCare Partners Inc (DVA): Four Robust Investments in Dialysis and Diabetes
Shares of the two largest kidney care companies in the United States, DaVita HealthCare Partners Inc (NYSE:DVA) and Fresenius Medical Care AG & Co.
DaVita HealthCare Partners Inc (DVA), Fresenius Medical Care AG & Co. (ADR) (FMS), Merck & Co., Inc. (MRK): Four Robust Investments in Dialysis and Diabetes
Shares of the two largest kidney care companies in the United States, DaVita HealthCare Partners Inc (NYSE:DVA) and Fresenius Medical Care AG & Co.
Baxter International Inc. (BAX): One Pharma Stock Investors Should Watch
Baxter International Inc. (NYSE:BAX), one of the fastest-growing healthcare multinational corporations of America, has a long history of strong financial credentials.
Should You Avoid Fresenius Medical Care AG & Co. (ADR) (FMS)?
Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) was in 6 hedge funds' portfolio at the end of the first quarter of 2013.
